two exciting new drugs for rheumatoid arthritis
You'll soon see two exciting new drugs for rheumatoid arthritis...Arava (Ah-RAY-va, leflunomide) and Enbrel (EN-brel, etanercept).
These will be the first disease-modifying drugs for rheumatoid arthritis (RA) to be approved in over 10 years.
Disease-modifying drugs actually slow joint destruction...aspirin and NSAIDs just relieve symptoms.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote